We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,154.00
Bid: 12,152.00
Ask: 12,156.00
Change: -16.00 (-0.13%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BUZZ-U.S. STOCKS ON THE MOVE-Lands' End, City National, Covenant

Thu, 22nd Jan 2015 14:20

(For faster updates on individual market-movers, Eikon usersplease use search string "STXBZ US"; for the Day Aheadnewsletter, http://link.reuters.com/mex49s; for the Morning NewsCall newsletter, http://link.reuters.com/nex49s) U.S. stock index futures pointed to modest gains at the open onThursday after the European Central Bank announced expandedmeasures to stimulate the region's economy. Dow Jones industrialaverage e-mini futures were up 0.54 percent at 17,585,S&P 500 e-mini futures were up 0.64 percent at 2,039.5and Nasdaq 100 e-mini futures were up 0.55 percent at4,205.75.

** LANDS' END INC , Wednesday close $50.71, -21.91pct premarket

The apparel retailer forecast lower revenue from merchandisesales and services in the fourth quarter. "We were disappointedby the performance of our cold weather assortment, especiallyduring the peak holiday period," Chief Executive Edgar Hubersaid. International business was affected by unfavorable changesin currency exchange rates and lower sales in Europe. Thecompany, spun off from Sears Holdings Corp last year,forecast Q4 earnings much below analysts' average estimate.

** CITY NATIONAL CORP, Wednesday close$74.57, +18.40 pct premarket

Royal Bank of Canada said it would buy theU.S. lender serving high net worth clients in a cash-and-stockdeal valued at $5.4 billion. RBC offered $47.25 in cash and0.7489 in shares for each City National share. The total offerof $93.80 per share, based on RBC's closing price of $62.16 onthe New York Stock Exchange on Wednesday, represents a premiumof nearly 26 percent to City National's last closing price.

** F5 NETWORKS INC, Wednesday close $125.95, -14.41pct premarket

The network equipment maker reported revenue that missedWall Street's estimates for the first time in eight quarters dueto "a marked decrease in the number of deals greater than $1million".

At least 8 brokerages cut price targets on the stock by asmuch as $25 to as low as $105; Median target price $133

"Comps become much more difficult in the coming quarters andthe company will have to prove that newer initiatives likesecurity can drive revenue re-acceleration and sustainabledouble-digit growth" Barclays analysts wrote in a note.

** LOGITECH INTERNATIONAL SA, Wednesday close$14.09, +8.16 pct premarket

The company increased profitability outlook for full year2015. The traders cited strong EBIT number of $76.4 mln for thethird quarter. The stock was the top riser on Stoxx 600, with a full-day's 30-day average volume alreadytraded.

** PETROBRAS , Wednesday close $7.35, +5.71 pctpremarket

** TOTAL SA , Wednesday close $51.64, +0.35 pctpremarket

** BP Plc , Wednesday close $38.82, +0.41 pctpremarket

** HALLIBURTON CO , Wednesday close $40.69, +0.27pct premarket

** SCHLUMBERGER LTD , Wednesday close $82.21, +0.57pct premarket

** SEADRILL LTD , Wednesday close $10.38, +3.37 pctpremarket

** TRANSOCEAN LTD , Wednesday close $16.06, +1.49pct premarket

** NABORS INDUSTRIES LTD , Wednesday close$10.86, +1.20 pct premarket

Brent crude rose ahead of an expected decision by EuropeanCentral Bank to start buying bonds, a move which could pushdollar to new highs and put downward pressure on commodities.Brent crude up 2 pct at $49.99 per barrel; U.S. crude up 1.5 pct at $48.49 per barrel.

** BLACKBERRY LTD, Wednesday close $9.93, +5.54 pctpremarket

Samsung Electronics Co Ltd is actively pursuinga plan to take over or buy a significant stake in the canadiancompany despite statements from both companies this weekdenying that such a plan may be in the works, Canada's FinancialPost reported. (http://bit.ly/1wpG0Ue)

** XILINX INC, Wednesday close $41.51, -7.25 pctpremarket

The programmable-chip maker's shares forecast Q3 revenue andQ4 revenue below analysts' average estimates. Results andforecast hurt by weak sales to broadcast and communicationscustomers.

At least nine brokerages cut price targets, with Robert W.Baird & Co slashing by $8.00 to $44.00

** MEDIVATION , Wednesday close $111.2, -3.39 pctpremarket

The drug developer says its prostate cancer therapy Xtandiwas not as safe as AstraZeneca Plc's treatment Casodexin a mid-stage study. 31 pct patients given Xtandi had seriousadverse reactions compared with 23.3 pct patients who were givenCasodex. Xtandi increased the time patients survived withoutprogression of the disease to 15.7 months, compared to 5.8months among Casodex patients.

** COVENANT TRANSPORTATION, Wednesday close$24.76, +9.05 pct premarket

The transportation services provider's Q4 earnings 82 centsper share came above the average analyst estimate 74 cents. Peakholiday shipping, lower fuel costs boosted profit, CEO DavidParker said.

** SANDISK CORP, Wednesday close $80.44, -6.51 pctpremarket

The memory chip maker forecast current-quarter andfull-year 2015 revenue well below Wall Street expectations,saying it would be unable to meet demand for flash memorystorage chips until mid-year due to lean inventory levels.

** KERYX BIOPHARMACEUTICALS INC, Wednesday close$12.87, -2.41 pct premarket

The drug developer's offering of 9.2 mln shares priced at$12 each, a discount of 6.8 pct to Wednesday's close. Thecompany, which had 91.9 mln shares outstanding as of Wednesday'sclose, said it would use $110 mln proceeds to fund marketing ofrecently approved chronic kidney disease treatment Auryxia.

** INTREXON CORP, Wednesday close $28.4, -1.37 pctpremarket

The synthetic biology company's offering of 3.8 millionshares priced at $27.00 each, a discount of 4.9 pct to thestock's Wednesday's closing price. Company had about 100.5 mlnshares outstanding as of Wednesday, according to Thomson Reutersdata.

** BIOMARIN PHARMACEUTICAL INC, Wednesday close$96.14, -2.86 pct premarket

The drugmaker's offering of 8.5 mln shares priced at $93.25each, a 3 pct discount to the stock's Wednesday close. THecompany had 147.4 mln shares outstanding as of Sept. 30,according to Thomson Reuters data. Says to use net proceeds tofund acquisition of Dutch drug developer Prosensa Holding NV and for general corporate purposes.

** AMERICAN EXPRESS CO, Wednesday close$87.67, -2.69 pct premarket

The world's largest credit card issuer will cut more than4,000 jobs this year, an executive said, after the credit cardcompany also reported higher quarterly expenses and provisionsfor bad loans. The planned redundancies, from a workforce ofnearly 63,000, contributed to a $313 million pre-taxrestructuring charge.

Jefferies cuts price target to $90 from $95, Barclays to $96from $100, and Bernstein to $97 from $99.

** EBAY INC, Wednesday close $53.38, +3.03 pctpremarket

The company plans to break up into three different companiesto accommodate would-be suitors, signaling a potential mergerfight after the breakup.

The company plans to spin off its payments division,PayPal, from its core marketplace division in the second half ofthe year, making two standalone publicly traded companies thatsome analysts say could be worth more than the combinedentity.

Cowen and Co raises price target to $57 from $55, RBCCapital Markets to $58 from $55 and Susquehanna Financial Groupto $59 from $52.

** VERIZON COMMUNICATIONS INC, Wednesday close$48.25, -0.41 pct premarket

THe company's quarterly revenue rose 6.8 percent due tohigher net addition of postpaid subscribers and a rise inaverage revenue per account as users added more devices toshared data plans. The company, however, reported a loss of$2.15 billion, or 54 cents per share, for the fourth quartercompared with a profit of $7.92 billion, or $1.76 per share, ayear earlier, mainly due to valuation of benefits plan andpension adjustments.

** MICROSOFT CORP, Wednesday close $45.92, +0.78pct premarket

The ageing tech pioneer surprised the tech world onWednesday with a prototype hologram visor that can bring theMinecraft video game, Skype calls and even the landscape of Marsto three-dimensional life.

** SALLIE MAE CORP, Wednesday close $9.69, -13.21pct premarket

The provider of student loans forecasted 2015 EPS of 48-50cents below analysts average estimate of 62 cents, according toThomson Reuters I/B/E/S. Net income for the fourth quarterplunged 75 pct to $14.9 million, missing analysts' averageestimate. Provision for loan losses rises 7 pct to $30 millionin Q4.

** FAMILY DOLLAR STORES INC, Wednesday close $75.55

The shareholders are expected to vote in favor of a pending$8.5 billion merger with Dollar Tree Inc despite ahigher offer from Dollar General still on the table,according to people familiar with the matter.

The vote, which is scheduled for Thursday, comes afterinfluential proxy advisory firm Institutional ShareholderServices said Dollar Tree's proposal was in the best interest ofshareholders and was more likely to close as it faces fewerantitrust hurdles than the Dollar General offer. (Compiled by Rosmi Shaji in Bengaluru; Edited by Don Sebastian)

More News
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.